MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN)

Cell and Bioscience

Volumn 4, Issue 1, 2014, Pages

  Zhou, Weidong ^a,b   Shi, Guixiu ^a   Zhang, Qiuyan ^b   Wu, Qiuwan ^a   Li, Boan ^b   Zhang, Zhiming ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Breast cancer; MiR 20b; Posttranscriptional regulation; PTEN

Indexed keywords

EID: 85027935984     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-4-62     Document Type: Article

References (31)

1. Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG: Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med (Berl) 1997, 75:429-439 10.1007/s001090050128.
2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5
3. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20 10.1016/j.cell.2004.12.035.
4. Yang Z, Wang L: Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci 2011, 1:31 10.1186/2045-3701-1-31.
5. Macfarlane LA, Murphy PR: MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics 2010, 11:537-561 10.2174/138920210793175895.
6. Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Zhu XY: Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers. Asian Pac J Cancer Prev 2012, 13:1901-1906 10.7314/APJCP.2012.13.5.1901.
7. Sun Y, Wu J, Wu SH, Thakur A, Bollig A, Huang Y, Liao DJ: Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res Treat 2009, 118:185-196 10.1007/s10549-008-0171-6.
8. Tanzer A, Stadler PF: Molecular evolution of a microRNA cluster. J Mol Biol 2004, 339:327-335 10.1016/j.jmb.2004.03.065.
9. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005, 65:9628-9632 10.1158/0008-5472.CAN-05-2352.
10. Landais S, Landry S, Legault P, Rassart E: Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007, 67:5699-5707 10.1158/0008-5472.CAN-06-4478.
11. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y, Ogawa R, Harata K, Fujii Y: microRNA expression profile in undifferentiated gastric cancer. Int J Oncol 2009, 34:537-542.
12. Lei Z, Li B, Yang Z, Fang H, Zhang GM, Feng ZH, Huang B: Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 2009, 4:e7629 10.1371/journal.pone.0007629.
13. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N, Russo A: miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 2010, 224:242-249.
14. Li D, Ilnytskyy Y, Kovalchuk A, Khachigian LM, Bronson RT, Wang B, Kovalchuk O: Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer. Oncotarget 2013, 4:1373-1387.
15. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947 10.1126/science.275.5308.1943.
16. Hollander MC, Blumenthal GM, Dennis PA: PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 2011, 11:289-301 10.1038/nrc3037.
17. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, Lieberman J, Rigoutsos I, Pandolfi PP: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011, 147:344-357 10.1016/j.cell.2011.09.029.
18. Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang HH, Liu X, Liang DS, Lu YJ, Shan HL, Jiang HC: Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell Physiol Biochem 2012, 30:631-641 10.1159/000341444.
19. Fu LL, Wen X, Bao JK, Liu B: MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 2012, 44:733-736 10.1016/j.biocel.2012.02.004.
20. Chalhoub N, Baker SJ: PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009, 4:127-150 10.1146/annurev.pathol.4.110807.092311.
21. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009, 23:1327-1337 10.1101/gad.1777409.
22. Wu W, Yang J, Feng X, Wang H, Ye S, Yang P, Tan W, Wei G, Zhou Y: MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer 2013, 12:30 10.1186/1476-4598-12-30.
23. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006, 130:2113-2129 10.1053/j.gastro.2006.02.057.
24. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008, 68:425-433 10.1158/0008-5472.CAN-07-2488.
25. Wang ZX, Lu BB, Wang H, Cheng ZX, Yin YM: MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res 2011, 42:281-290 10.1016/j.arcmed.2011.06.008.
26. Liang Z, Li Y, Huang K, Wagar N, Shim H: Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN. Pharm Res 2011, 28:3091-3100 10.1007/s11095-011-0570-y.
27. Ma F, Zhang J, Zhong L, Wang L, Liu Y, Wang Y, Peng L, Guo B: Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/beta-catenin signaling. Gene 2014, 535:191-197 10.1016/j.gene.2013.11.035.
28. Zhu J, Chen L, Zou L, Yang P, Wu R, Mao Y, Zhou H, Li R, Wang K, Wang W, Hua D, Zhang X: MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer. Hum Immunol 2014, 75:348-353 10.1016/j.humimm.2014.01.006.
29. Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W, Zhou Y, Ou Y, Lin X, Lin Y, Xu D, Yan G: Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer 2011, 10:59 10.1186/1476-4598-10-59.
30. Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng Q, Lan K: A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKepsilon. Cell Res 2011, 21:793-806 10.1038/cr.2011.5.
31. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408 10.1006/meth.2001.1262.